Clinical trials show approximately 50% of lost weight returns within 12 months after discontinuation, though individual results range from 20% to 100% regain
As a result, the individual isnt tempted to consume as many calories
Takeaway: For HFpEF patients with obesity + T2D, GLP-1s and dual agonists are emerging not only as metabolic therapies but as cardiovascular disease-modifying agents
However, any meaningful weight losswhether achieved through medication, dietary changes, bariatric surgery, or intensive lifestyle treatmentcan include some reduction in lean mass
Choosing the Right Probiotic While on GLP-1 Treatment Selecting an appropriate probiotic supplement requires careful consideration, as not all products are equivalent in quality, strain composition, or evidence base
More tired